FDA Removes Warnings, Boosting Access to Menopause Hormone Therapy
TL;DR Summary
The FDA plans to remove the 'black box' warning labels from many menopause hormone therapy drugs, acknowledging that previous fears based on flawed research led to millions of women being denied beneficial treatment, which could improve heart health, cognitive function, and bone density. FDA Commissioner Dr. Marty Makary called the demonization of hormone therapy an 'American tragedy' and emphasized the importance of updated, nuanced understanding and patient-doctor discussions.
- FDA chief says warning labels deterred women from using menopause hormone therapy: "It's an American tragedy" CBS News
- Opinion | Marty Makary: The FDA Liberates Women’s Hormone Replacement Therapy The Wall Street Journal
- ‘Black box’ safety warning to be removed from hormone therapy for menopause CNN
- FDA Removes Warnings From Menopause Treatment Labels Bloomberg.com
- FDA reverses decades-old warning on hormone therapy products for menopause statnews.com
Reading Insights
Total Reads
0
Unique Readers
1
Time Saved
5 min
vs 6 min read
Condensed
94%
1,090 → 68 words
Want the full story? Read the original article
Read on CBS News